US-based Catalent has unveiled a new solution to support trial sponsors with clinical supply chain planning.
The CTSuccess clinical trial planning service is designed to reduce the risk of delays and costs as the studies progress further.
Catalent’s new CTSuccess solution uses the company’s proprietary StartScore evaluation tool to measure the complexity of a potential clinical project featuring a number of study characteristics.
Designed and developed by the company’s in-house expert team, the StartScore model is based on actual performance data.
The StartScore evaluation tool generates a risk-based score that enables sponsors to gain a better understanding of the clinical supply management.
It also enables the sponsors to start their clinical project on-time and maintain momentum upon the progression of the study.
Catalent Clinical Supply Services global director Kristen Devito said: “No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise.
“Once these risks have been identified then a project team can be put together combining the necessary expertise to provide the integrated services and tailored support to ensure continuity of supply from beginning to end.”
Nine current good manufacturing practice (cGMP)-certified clinical packaging facilities are part of the company’s clinical supply network across Asia, Europe and North America.
Catalent also has over 50 depots in strategic locations around the world.